Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-04-21Clinical Trial Update: Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes [NA]
This clinical trial update notes the completed study comparing metabolic surgery versus medical management for the resolution of Type 2 Diab…
-
FDA approval · 2015-04-20FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) submitted by MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Arginase Inhibition in Ischemia-reperfusion Injury [Phase 1]
Phase 1 trial evaluating an arginase inhibitor for ischemia-reperfusion injury has completed. The study enrolled individuals with coronary a…
-
FDA approval · 2015-04-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2015-04-17FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approved a supplemental application for AFREZZA (insulin human) submitted by MannKind Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluating MBX-2982 as monotherapy for type 2 diabetes completed, assessing efficacy, safety, tolerability, and pharmacokine…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin [Phase 2]
A Phase 2 clinical trial evaluating MBX-102 for safety and effectiveness in adults with type 2 diabetes mellitus inadequately controlled on …
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 2, Phase 3]
A clinical trial evaluating denagliptin in adults with type 2 diabetes mellitus (Phase 2/3) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control [NA]
A completed clinical trial evaluated whether a Diabetes Transitions Tool Kit improves post-hospitalization glycemic control in adults with T…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Pilot Study of Vedic Medicine for Type 2 Diabetes [Phase 2]
A Phase 2 pilot trial evaluating Vedic Medicine for Type 2 diabetes has completed.
-
FDA approval · 2015-04-15FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for bromocriptine mesylate (Padagis US LLC).
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension [Phase 4]
Phase 4 trial comparing carvedilol vs metoprolol to evaluate glycemic control in patients with type 2 diabetes mellitus and hypertension; st…
-
CLINICAL_TRIALS research · 2015-04-15Clinical Trial Update: GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients [Phase 2]
Phase 2 trial evaluating GSK189075 and GW869682 against placebo in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes [Phase 2]
A Phase 2 trial comparing Biphasic Human Insulin with EX1000 in Type 2 diabetes completed, assessing safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension [Phase 4]
A Phase 4 trial comparing carvedilol versus metoprolol on glycemic control in patients with type 2 diabetes and hypertension has completed. …
-
FDA approval · 2015-04-13FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Metformin Hydrochloride from Zydus Lifesciences Limited, finalizing a change to this generic pro…
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial assessing the effect of pioglitazone on left ventricular diastolic function in type 2 diabetes mellitus was withdra…
-
CLINICAL_TRIALS research · 2015-04-10Clinical Trial Update: Functional MRI Biomarkers of Cognitive Decrements in Diabetes
A completed clinical trial evaluating functional MRI biomarkers of cognitive decrements in people with Type 2 diabetes and metabolic syndrom…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Interactive Tool to Support Self-management Through Lifestyle Feedback, Aimed at Physical Activity of COPD/DM Patients [NA]
Update on a completed clinical trial evaluating an interactive self-management tool that provides lifestyle feedback to improve physical act…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) [Phase 3]
Phase 3 trial DEMAND evaluating the combination of delapril and manidipine for nephroprotection in diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial assessing the safety and tolerability of lixisenatide as monotherapy in adults with type 2 diabetes has been completed.
-
CLINICAL_TRIALS research · 2015-04-09Clinical Trial Update: A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
A completed clinical trial update from Novo Nordisk describing a survey of hypoglycemia in insulin-treated patients with diabetes.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy [Phase 2]
A Phase 2 study of NCX4016 in patients with Type 2 diabetes and early nephropathy was terminated. No efficacy or safety results are provided…
-
CLINICAL_TRIALS research · 2015-04-08Clinical Trial Update: Breakfast on Postprandial Hyperglycemia [NA]
This clinical trial update addresses breakfast and its effect on postprandial hyperglycemia in adults with Type 2 diabetes, with Hospital de…
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics [Phase 4]
This document describes a Phase 4 double-blind, placebo-controlled trial of empagliflozin (JARDIANCE) in individuals with type 2 diabetes an…